->

Tag: Tisagenlecleucel

Home / Yakagadzwa Gore

, , , , , ,

Tisagenlecleucel inotenderwa neFDA yekudzokorora kana refractory follicular lymphoma

Chikumi 2022: Mushure memitsara miviri kana kupfuura yesystemic therapy, FDA yakapa tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yakakurumidza kubvumidza kuvarwere vakura vane relapsed kana refractory follicular lymphoma (FL) T.

Mitsva-mishonga-in-advanced-cancer-therapy
, , , , , , , , , , , ,

Dzazvino mishonga yekurapa kenza

Chikunguru 2021: Tarisa uone mishonga ichangoburwa mukurapa cancer. Gore rega rega, mushure mekuongorora miedzo uye zvimwe zvakakosha, USFDA inobvumidza mishonga, uye nekudaro varwere vegomarara vanogona kutenda kuti kurapwa kwave pedyo. ..

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa